Publication | Open Access
Monotherapy treatment success rate of omapatrilat, a vasopeptidase inhibitor, compared with lisinopril and amlodipine in mild to moderate hypertension
15
Citations
0
References
1999
Year
HypertensionCardiovascular DiseaseMedicineAntihypertensive TherapyCardiovascular PharmacologyPharmacotherapyVasopeptidase InhibitorPharmacology
No additional data available for this publication yet. Check back later!